Caris Life Sciences, Inc. (CAI) stock
CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30121% above fair value
$23.04−0.92 (-3.84%)
Close on Nov 13, 2026Market cap $6.51BP/E –Yield –
Caris Life Sciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Caris Life Sciences's enterprise value was $7.21B on Nov 11, 2026, against $6.82B a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.21B | -0.3% |
| 2025 | Dec 31, 2025 | $7.23B | – |
See a number that looks wrong?